Ravulizumab for relapse prevention in AQP4-IgG–positive neuromyelitis optica spectrum disorder: a 2-year follow-up case report
BackgroundNeuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system, distinct from multiple sclerosis, characterized by severe inflammatory attacks targeting the optic nerves, spinal cord, and brainstem. Treatment has evolved from broad immunosuppressa...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-06-01
|
| Series: | Frontiers in Medicine |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1827687/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|